U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106788) titled 'Aveir Leadless Pacemaker Japan PMS' on July 30.
Brief Summary: The primary purpose of the PMS is to collect safety information on the Aveir DR leadless cardiac pacemaker (LP) system in a population indicated for de novo dual-chamber pacing. Additionally, the PMS will collect data on rollover patients from the Aveir DR i2i IDE, Aveir AR LP in patients indicated for single-chamber pacing in the right atrium, and upgradeability in patients implanted with single-chamber Aveir atrial or ventricular LP that require an upgrade to a dual-chamber Aveir LP.
Study Start Date: May 26
Study Type: OBSERVATIONAL
Condition:
Leadless Pacemaker
I...